Fulton Breakefield Broenniman’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,810
| Closed | -$215K | – | 189 |
|
|
2024
Q2 | $215K | Buy |
+1,810
| New | +$215K | 0.02% | 176 |
|
|
2023
Q3 | – | Sell |
-1,755
| Closed | -$213K | – | 170 |
|
|
2023
Q2 | $213K | Sell |
1,755
-4
| -0.2% | -$486 | 0.02% | 168 |
|
|
2023
Q1 | $270K | Buy |
1,759
+4
| +0.2% | +$614 | 0.02% | 146 |
|
|
2022
Q4 | $315K | Hold |
1,755
| – | – | 0.03% | 143 |
|
|
2022
Q3 | $208K | Hold |
1,755
| – | – | 0.02% | 156 |
|
|
2022
Q2 | $251K | Sell |
1,755
-50
| -3% | -$7.15K | 0.02% | 152 |
|
|
2022
Q1 | $311K | Hold |
1,805
| – | – | 0.03% | 135 |
|
|
2021
Q4 | $458K | Sell |
1,805
-150
| -8% | -$38.1K | 0.03% | 137 |
|
|
2021
Q3 | $752K | Buy |
1,955
+45
| +2% | +$17.3K | 0.06% | 92 |
|
|
2021
Q2 | $449K | Hold |
1,910
| – | – | 0.04% | 134 |
|
|
2021
Q1 | $250K | Hold |
1,910
| – | – | 0.02% | 161 |
|
|
2020
Q4 | $200K | Buy |
+1,910
| New | +$200K | 0.02% | 134 |
|